Axa S.A. Gilead Sciences, Inc. Transaction History

Axa S.A.

$33.6 Billion
Q2 2025

A detailed history of Axa S.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Axa S.A. holds 1,602,225 shares of GILD stock, worth $193 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

1,602,225

Previous 1,604,489 0.14%

Holding current value

$193 Million

Previous $180 Million 1.19%

% of portfolio

0.53%

Previous 0.61%

37 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$96.91 - $113.0 $219,404 - $255,832	-2,264 Reduced 0.14%	1,602,225 $178 Million
Q1 2025 May 15, 2025	SELL	$89.14 - $117.41 $17.4 Million - $23 Million	-195,568 Reduced 10.86%	1,604,489 $180 Million
Q4 2024 Feb 14, 2025	BUY	$83.95 - $97.9 $16.9 Million - $19.8 Million	201,769 Added 12.62%	1,800,057 $166 Million
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $9.83 Million - $12.4 Million	-147,593 Reduced 8.45%	1,598,288 $134 Million
Q2 2024 Feb 25, 2025	SELL	$63.15 - $72.88 $3.42 Million - $3.95 Million	-54,176 Reduced 3.01%	1,745,881 $120 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $12.2 Million - $14.1 Million	-193,526 Reduced 9.98%	1,745,881 $120 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $9.14 Million - $11.1 Million	127,661 Added 7.05%	1,939,407 $142 Million
Q4 2023 Jul 16, 2024	SELL	$73.27 - $83.09 $9.35 Million - $10.6 Million	-127,661 Reduced 6.58%	1,811,746 $147 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $4.76 Million - $5.4 Million	64,985 Added 3.72%	1,811,746 $147 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $6.35 Million - $6.92 Million	85,819 Added 5.17%	1,746,761 $131 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $13.7 Million - $15.6 Million	-180,360 Reduced 9.8%	1,660,942 $128 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $51 Million - $58.1 Million	660,135 Added 55.89%	1,841,302 $153 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $18.5 Million - $26.6 Million	-297,313 Reduced 20.11%	1,181,167 $101 Million
Q3 2022 Feb 14, 2023	SELL	$59.54 - $68.01 $21.8 Million - $24.9 Million	-366,793 Reduced 19.88%	1,478,480 $91.2 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $21.8 Million - $24.9 Million	-366,793 Reduced 19.88%	1,478,480 $91.2 Million
Q2 2022 Feb 14, 2023	SELL	$57.72 - $65.01 $9.43 Million - $10.6 Million	-163,453 Reduced 8.14%	1,845,273 $114 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $9.43 Million - $10.6 Million	-163,453 Reduced 8.14%	1,845,273 $114 Million
Q1 2022 Feb 14, 2023	BUY	$57.92 - $72.58 $30.7 Million - $38.5 Million	530,246 Added 35.86%	2,008,726 $119 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $2.65 Million - $3.32 Million	-45,795 Reduced 2.23%	2,008,726 $119 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $10.9 Million - $12.4 Million	168,312 Added 8.92%	2,054,521 $149 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $33.4 Million - $36 Million	492,818 Added 35.37%	1,886,209 $132 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $26.4 Million - $28.9 Million	416,188 Added 42.59%	1,393,391 $95.9 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $3.9 Million - $4.45 Million	-64,943 Reduced 6.23%	977,203 $63.2 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $182,922 - $208,431	-3,229 Reduced 0.31%	1,042,146 $60.7 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $13.3 Million - $16.7 Million	-214,033 Reduced 16.99%	1,045,375 $66.1 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $1.01 Million - $1.17 Million	-13,928 Reduced 1.09%	1,259,408 $96.9 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $9.57 Million - $12.3 Million	-152,844 Reduced 10.72%	1,273,336 $95.2 Million
Q4 2019 Feb 18, 2020	SELL	$61.62 - $67.78 $12.3 Million - $13.6 Million	-200,196 Reduced 12.31%	1,426,180 $92.7 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $4.97 Million - $5.49 Million	-79,561 Reduced 4.66%	1,626,376 $103 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $2.96 Million - $3.32 Million	47,922 Added 2.89%	1,705,937 $115 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $53.2 Million - $59.6 Million	851,198 Added 105.5%	1,658,015 $108 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $4.86 Million - $6.34 Million	-80,241 Reduced 9.05%	806,817 $50.5 Million
Q3 2018 Nov 08, 2018	BUY	$71.28 - $78.92 $7.16 Million - $7.93 Million	100,458 Added 12.77%	887,058 $68.5 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $1.47 Million - $1.72 Million	-22,724 Reduced 2.81%	786,600 $55.7 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $38.2 Million - $46.6 Million	-524,306 Reduced 39.31%	809,324 $61 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $104 Million - $122 Million	-1,465,253 Reduced 52.35%	1,333,630 $95.5 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $202 Million - $239 Million	2,798,883	2,798,883 $227 Million

Others Institutions Holding GILD

# of Institutions

2,342

Shares Held

1.03B

Call Options Held

12.1M

Put Options Held

9.13M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $151B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account